See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2021_PROVECTUS_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000315545')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000315545, PROVECTUS BIOPHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 423,679 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 44,701 |
| 3 | remainder_Assets | 120,821 |
| 4 | LiabilitiesCurrent | 30,711,714 |
| 5 | LiabilitiesNoncurrent | 44,783 |
| 6 | remainder_Liabilities | 39,061 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,150,816 |
| 9 | ResearchAndDevelopmentExpense | 2,812,760 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,714,011 |
| 13 | remainder_ComprehensiveNetIncome | -10,089 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 589,201 |
| 1 | Liabilities | 30,795,558 |
| 2 | Expenses | 4,963,576 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -30,206,357 |
| 5 | NetIncome | -6,677,587 |
| 6 | ComprehensiveNetIncome | -6,682,632 |
| 7 | BaseVar | 19,036,218 |
| 8 | EconomicCapitalRatio | -3.74 |
Edgar->Model Mapping
Feature Distribution
Change over Time
